Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06213883 · ClinicalTrials.gov registry record · NA

Response to Acute Exercise in Eating Disorders

A NA study, sponsored by University of Wisconsin, Madison.

Completed
Registry status
NA
Development phase
74
Enrollment target

NCT06213883 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 74 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06213883, a NA study, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
NA
Development phase
74 participants
Enrollment target

Study Summary

Individuals with eating disorders (ED) represent a high-priority clinical population, with among the highest mortality rates of any psychiatric disorder, and driven exercise (DEx) is a symptom evidenced in up to 80% of those with EDs that increases impairment and negatively impacts treatment outcome. This study will develop tasks to characterize cognitive, affective, and biological response to exercise among adolescent and young adult females with EDs and determine whether acute exercise response associates with free-living activity and DEx. This R21 project will provide foundational data to guide research and development of treatments that are more precisely targeted to the symptom of driven exercise and to ultimately improve clinical outcomes associated with EDs.

Interventions

  • OTHER Biobehavioral Response to in-lab exposure to physical activity

Trial Details

FieldValue
Enrollment Target 74 participants
Start Date 2023-11-02
Est. Completion 2025-07-31
Phase NA

Sponsor

University of Wisconsin, Madison

1,039 total trials

What the Registry Record Tells You About NCT06213883

The ClinicalTrials.gov registry entry for NCT06213883 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Biobehavioral Response to in-lab exposure to physical activity is the first listed.

NCT06213883 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06213883 about?

NCT06213883 is a clinical study titled "Response to Acute Exercise in Eating Disorders". Individuals with eating disorders (ED) represent a high-priority clinical population, with among the highest mortality rates of any psychiatric disorder, and driven exercise (DEx) is a symptom evidenced in up to 80% of those with EDs that increases impairment and negatively impacts treatment outcome...

What is the current status of trial NCT06213883?

This trial is currently completed. It is a NA study. The enrollment target is 74 participants. The study started on 2023-11-02. Estimated completion is 2025-07-31.

What interventions are being tested in trial NCT06213883?

The interventions under investigation include: Biobehavioral Response to in-lab exposure to physical activity (OTHER).

Who is sponsoring clinical trial NCT06213883?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.